S. 7 · 108th Congress

Prescription Drug Benefit and Cost Containment Act of 2003

Stage
In committee
Sponsor
Tom Daschle
Introduced
2003-01-07
Latest action
2003-01-07 · Introduced in Senate

Subjects

Congress
Government trust funds
Medicare
Veterans' medical care
Health
Law
Medicaid
Child health
Families
Drug therapy
Education
Department of Health and Human Services
Commerce
District of Columbia
Right of privacy
Intellectual property
Canada
Business records
Science, Technology, Communications
Civil Rights and Liberties, Minority Issues
Armed Forces and National Security
Government Operations and Politics
Labor and Employment
Economics and Public Finance
Crime and Law Enforcement
Social Welfare
Metropolitan areas
Urban affairs
Hospitals
Congressional reporting requirements
Emergency medicine
Finance and Financial Sector
Health insurance
Consumer education
Imports
Governmental investigations
Health education
Auditing
Communication in medicine
Drug approvals
Drugs
Federal advisory bodies
Fraud
Medical economics
Medical fees
Pharmaceutical research
Prescription pricing
Veterans' benefits
Restrictive trade practices
Standards
Employee health benefits
Health insurance continuation
Housing and Community Development
Patients' rights
Rural health
Home care services
Administrative procedure
Technological innovations
Information networks
Judicial opinions
Judicial review
Right of petition
Fines (Penalties)
Independent regulatory commissions
Injunctions
Territories (U.S.)
Grants-in-aid
Federal aid to health facilities
Labeling
Patent infringement
Patents
Fees
Employee benefit plans
Medical records
Retiree health benefits
Medical statistics
Federal Trade Commission
Drug industry
Generic drugs
Health care fraud
Health maintenance organizations
Pharmacies
Continuum of care
Kidney diseases
Rebates
Managed care
Ambulatory care
Health information systems
Marketing
Surveys
Drug interactions
Electronic data interchange
Conflict of interests
Transplantation of organs, tissues, etc.
Mail-order business
Medigap
Consent decrees
Immunosuppressive drugs
Medication abuse
Quality control
Health services administration
Drug advertising
Consumer organizations